Bcel stock forecast.

In 2021 and 2020, respectively 14 and 13 companies raised sums of $250m or more, whilst in 2019 and 2018, the numbers were 3 and 2. Atreca Inc ( NASDAQ: BCEL) IPOd in June 2019, raising ~$114m at ...

Bcel stock forecast. Things To Know About Bcel stock forecast.

The stock market is getting a jolt from the inflation report. All three major U.S. stock indexes jumped more than 1% Tuesday morning, with the coming close to a 2% gain.Price target. 3.25 0.00 0.00%. The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — and a min estimate of —. Aug 14, 2023 · BCEL Earnings Date and Information. Atreca last posted its quarterly earnings data on May 10th, 2023. The reported ($0.54) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.56) by $0.02. Atreca has generated ($2.18) earnings per share over the last year ( ($2.18) diluted earnings per share). Average. $3.25. Current Price. $0.21. Options. Overview. Research & Ratings. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume ...

Stock Price Forecast. The 17 analysts offering 12-month price forecasts for BCE Inc have a median target of 41.19, with a high estimate of 45.64 and a low estimate of 39.16. The median estimate ...

For Atreca stock forecast for 2023, 1 predictions are offered for each month of 2023 with average Atreca stock forecast of $0.23, a high forecast of $0.23, and a low forecast of …

Atreca Inc - Class A Stock Chart and Share Price Forecast, Short-Term "BCEL" Stock Prediction for Next Days and Weeks Walletinvestor.com Atreca Inc - Class A (BCEL) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024Heading out for an outdoor adventure? Whether you’re planning a picnic, a hiking trip, or a beach day, one essential tool you need in your arsenal is a detailed weather 10 day forecast.ATRECA, INC. stock price forecast for further price development down to -100.00% (time horizon: 1 day) and price target of 0.00 USD. Negative news sentiment. Short-term (time horizon: 2 weeks) ATRECA, INC. share price prediction for 2024-01-12 with daily closed price projectionsThe current Atreca [ BCEL] share price is $0.21. The Score for BCEL is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. BCEL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.BCEL stock forecast Our latest prediction for Atreca Inc's stock price was made on the Aug. 7, 2023 when the stock price was at 0.91$.. In the short term (2weeks), BCEL's stock price should underperform the market by -3.07%.During that period the price should oscillate between -9.61% and +7.63%.. In the medium term (3months), BCEL's …

Find real-time BCE - BCE Inc stock quotes, company profile, news and forecasts from CNN Business.

Find the latest ADMA Biologics, Inc. (ADMA) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W ...

ENDRA Life Sciences Inc. 0.97. +0.01. +1.0417%. ARTH. Get Atreca Inc (BCEL:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.April 06, 2023 — 09:55 am EDT. Written by Zacks Equity Research for Zacks ->. Shares of Atreca, Inc. (BCEL) have been struggling lately and have lost 20% over the past week. However, a hammer ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL. Atreca Inc Cl A (BCEL) Company Description. Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism ...Atreca Inc [BCEL] stock prices are down -14.82% to $0.28 at the moment. ... An investor can expect a potential return of 1060.71% based on the average BCEL price forecast. Analyzing the BCEL fundamentals. In this publicly-traded organization, revenue per employee is $8,556, ...4/13 ratings generated profit. 31%. Average Return. -37.24%. reiterated a buy rating 10 months ago. Copying Do Kim 's trades and holding each position for 1 Year would result in 30.77% of your transactions generating a profit, with an average return of -37.24% per trade. 2 Years. dummy dummy.

Find real-time ALLK - Allakos Inc stock quotes, company profile, news and forecasts from CNN Business.Next reporting date. December 19, 2023. EPS forecast (this quarter) -$0.08. Annual revenue (last year) $130.5M. Annual profit (last year) -$142.7M. Net profit margin.Stocks & ETFs, MFs & FOREX. AI Trend Prediction Engine. Stocks & ETFs, MFs & FOREX3 Wall Street research analysts have issued 1-year price targets for Tecnoglass' shares. Their TGLS share price targets range from $43.00 to $54.00. On average, they anticipate the company's stock price to reach $48.20 in the next year. This suggests a possible upside of 30.2% from the stock's current price.The average one-year price target for BCEL / Atreca Inc - Class A is $3.315. The forecasts range from a low of $1.01 to a high of $9.45. A stock’s price target is the price at which analysts consider it fairly valued with respect to its …

Find real-time CBAY - CymaBay Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Stock Target Advisor’s own stock analysis of Atreca Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Atreca Inc’s stock price was USD 0.22. Atreca Inc’s stock price has changed by -5.11% over the past week, +8.25% over the past month and -79.54% over the last year.

BCEL BCEL Atreca Inc - Ordinary Shares - Class A 2,464 Watch Alerts $0.223 $0.0092 (4.30%) Today $0.23 0.0035 (1.57%) After Hours About Feed News Sentiment Earnings …About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception). Analysts have been projecting $1.00 as a low price target for the stock while placing it at a high target of $9.00. It follows that stock’s current price would drop -4400.0% in reaching the projected high whereas dropping to the targeted low would mean a loss of -400.0% for stock’s current value. Atreca Inc (BCEL) estimates and forecastsStock Price Forecast. The 10 analysts offering 12-month price forecasts for Viking Therapeutics Inc have a median target of 34.00, with a high estimate of 40.00 and a low estimate of 28.00. The ...VKTX Stock 12 Months Forecast. $34.00. (187.40% Upside) Based on 6 Wall Street analysts offering 12 month price targets for Viking Therapeutics in the last 3 months. The average price target is $34.00 with a high forecast of $40.00 and a low forecast of $28.00. The average price target represents a 187.40% change from the last price of $11.83. Tecnoglass Inc () Stock Market info Recommendations: Buy or sell Tecnoglass stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Tecnoglass share forecasts, stock quote and buy / sell signals below.According to present data Tecnoglass's TGLS shares and potentially its market environment have been in a bullish …Nov 30, 2023 · The Atreca Inc. stock price gained 5.36% on the last trading day (Friday, 17th Nov 2023), rising from $0.209 to $0.220. During the last trading day the stock fluctuated 9.33% from a day low at $0.210 to a day high of $0.230. The price has been going up and down for this period, and there has been a -16.59% loss for the last 2 weeks. About the Atreca Inc – Class A stock forecast. As of 2023 November 08, Wednesday current price of BCEL stock is 0.290$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts. Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Nu Holdings Ltd have a median target of 9.75, with a high estimate of 16.00 and a low estimate of 6.00. The median ...

Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ...

You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

Find the latest Atreca, Inc. (BCEL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. QFIN Stock 12 Months Forecast. $25.75. (85.12% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Qifu Technology in the last 3 months. The average price target is $25.75 with a high forecast of $27.00 and a low forecast of $24.50. The average price target represents a 85.12% change from the last price of $13.91.Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cymabay Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Cymabay Therapeutics's CBAY shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).Competitors. Stock Price Forecast. The 1 analysts offering 12-month price forecasts for Ideanomics Inc have a median target of 30,387.50, with a high estimate of 30,387.50 and a low estimate of ... The Cymabay Therapeutics Inc stock price gained 1.86% on the last trading day (Thursday, 30th Nov 2023), rising from $18.78 to $19.13. During the last trading day the stock fluctuated 4.76% from a day low at $18.89 to a day high of $19.79. The price has risen in 6 of the last 10 days and is up by 6.28% over the past 2 weeks.11.85 %. The 3 Wall Street analysts offering Atreca stock forecast in the last 6 months have average price target of $9.0 with a high forecast of $25.0 and a low forecast of $1.0. The average Atreca stock forecast represents a 3729.79% increase from the last price of $0.234999999403953. From AI system, total return is 2366.52% from 4098 forecasts.Atreca, Inc. (BCEL) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting stock ...View Tecnoglass Inc TGLS investment & stock information. Get the latest Tecnoglass Inc TGLS detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.See ENTHUSIAST GAMING HOLDINGS INC stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... Forecast . Price target. 1.93 0.00 0.00%. The 7 analysts offering 1 year price forecasts for EGLX have a max estimate of — and a min estimate of —.

Atreca stock forecast report. View BCEL price target, analyst ratings, upgrades & downgrades predictions, and buy or a sell data.BCEL is currently rated as a Sucker Stock | Stockopedia. Login Get Started. Sectors Healthcare Biotechnology & Medical Research Atreca. ... Is there a Atreca share price forecast for 2023? The analyst consensus target price for shares in Atreca is $3.25. That is 1420.11% above the last closing price of $0.21.Gas prices are at a record high, and experts are forecasting that prices could go higher this summer — perhaps $5 or even over $6 a gallon. By clicking "TRY IT", I agree to receive newsletters and promotions from Money and its partners. I a...Wall Street Stock Market & Finance report, prediction for the future: You'll find the Cheniere Energy share forecasts, stock quote and buy / sell signals below. According to present data Cheniere Energy's LNG shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).Instagram:https://instagram. grendierkgc stock price todaymovers after hoursenterprise product partners stock Stock Price Forecast. The 20 analysts offering 12-month price forecasts for Kroger Co have a median target of 51.75, with a high estimate of 65.00 and a low estimate of 37.00. The median estimate ... quantom energyww oprah See Atreca, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. ... The 4 analysts offering 1 year price forecasts for BCEL have a max estimate of — …The current average BCEL price target, as estimated by these analysts, is $4.00. The predictions for the future BCEL stock price range from a low of $4.00 to a high of $4.00, highlighting the variability of market expectations for BCEL. is pdi a good investment Based on 10 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. The average price target is $24.40 with a high forecast of $33.00 and a low forecast of $20.00. The average price target represents a 29.93% change from the last price of $18.78. Highest Price Target $33.00. Average Price Target $24.40.The BCEL shares have gain 4.62% over the last week, with a monthly amount glided 4.62%, and seem to be holding up well As of right now, Atreca Inc [BCEL] is trading at $0.22, up 2.19%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value.Nov 30, 2023 · 5 equities research analysts have issued twelve-month target prices for Atreca's stock. Their BCEL share price targets range from $4.00 to $25.00. On average, they expect the company's stock price to reach $10.75 in the next twelve months. This suggests a possible upside of 4,474.5% from the stock's current price.